5830 Federal Register / Vol. 76, No. 22 / Wednesday, February 2, 2011 / Notices investigated Cambridge Isotope Lab to Drug Schedule Drug Schedule ensure that the company’s registration is consistent with the public interest. The Oripavine (9330) ........................... II Secobarbital (2315) ...................... II investigation has included inspection Thebaine (9333) ........................... II Phenylacetone (8501) .................. II and testing of the company’s physical Oxymorphone (9652) ................... II Cocaine (9041) ............................. II Codeine (9050) ............................. II security systems, verification of the Phenazocine (9715) ..................... II Fentanyl (9801) ............................ II Dihydrocodeine (9120) ................. II company’s compliance with state and Oxycodone (9143) ........................ II local laws, and a review of the The company plans to manufacture Hydromorphone (9150) ................ II company’s background and history. small quantities of the listed controlled Diphenoxylate (9170) ................... II Ecgonine (9180) ........................... II Therefore, pursuant to 21 U.S.C. 823(a), substances as radiolabeled compounds and in accordance with 21 CFR 1301.33, Hydrocodone (9193) ..................... II for biochemical research. Meperidine (9230) ........................ II the above named company is granted No comments or objections have been registration as a bulk manufacturer of Methadone (9250) ........................ II received. DEA has considered the Morphine (9300) ........................... II the basic class of controlled substance factors in 21 U.S.C. 823(a) and Oxymorphone (9652) ................... II listed. determined that the registration of Alfentanil (9737) ........................... II Dated: January 18, 2011. American Radiolabeled Chemicals, Inc. Remifentanil (9739) ...................... II Sufentanil (9740) .......................... II Joseph T. Rannazzisi, to manufacture the listed basic classes Fentanyl (9801) ............................ II Deputy Assistant Administrator, Office of of controlled substances is consistent Diversion Control, Drug Enforcement with the public interest at this time. The company plans on manufacturing Administration. DEA has investigated American the listed controlled substances in bulk [FR Doc. 2011–2295 Filed 2–1–11; 8:45 am] Radiolabeled Chemicals Inc. to ensure for sale to its customers. BILLING CODE 4410–09–P that the company’s registration is No comments or objections have been consistent with the public interest. The received. DEA has considered the investigation has included inspection factors in 21 U.S.C. 823(a) and DEPARTMENT OF JUSTICE and testing of the company’s physical determined that the registration of Cody security systems, verification of the Drug Enforcement Administration Laboratories to manufacture the listed company’s compliance with state and basic classes of controlled substances is Manufacturer of Controlled local laws, and a review of the consistent with the public interest at Substances; Notice of Registration company’s background and history. this time. DEA has investigated Cody Therefore, pursuant to 21 U.S.C. 823(a), Laboratories to ensure that the By Notice dated August 3, 2010, and and in accordance with 21 CFR 1301.33, company’s registration is consistent published in the Federal Register on the above named company is granted with the public interest. The September 1, 2010, (75 FR 53720), registration as a bulk manufacturer of investigation has included inspection American Radiolabeled Chemicals, Inc., the basic classes of controlled and testing of the company’s physical 101 Arc Drive, St. Louis, Missouri substances listed. security systems, verification of the 63146, made application by renewal to Dated: January 18, 2011. company’s compliance with state and the Drug Enforcement Administration Joseph T. Rannazzisi, local laws, and a review of the (DEA) to be registered as a bulk Deputy Assistant Administrator, Office of company’s background and history. manufacturer of the following basic Diversion Control, Drug Enforcement Therefore, pursuant to 21 U.S.C. 823(a), classes of controlled substances: Administration. and in accordance with 21 CFR 1301.33, the above named company is granted Drug Schedule [FR Doc. 2011–2294 Filed 2–1–11; 8:45 am] BILLING CODE 4410–09–P registration as a bulk manufacturer of Gamma Hydroxybutyric Acid I the basic classes of controlled (2010). substances listed. Ibogaine (7260) ............................ I DEPARTMENT OF JUSTICE Dated: January 18, 2011. Lysergic acid diethylamide (7315) I Joseph T. Rannazzisi, Tetrahydrocannabinols (7370) ..... I Drug Enforcement Administration Dimethyltryptamine (7435) ........... I Deputy Assistant Administrator, Office of 1-[1-(2- I Manufacturer of Controlled Diversion Control, Drug Enforcement Thienyl)cyclohexyl]piperidine Substances; Notice of Registration Administration. (7470). [FR Doc. 2011–2291 Filed 2–1–11; 8:45 am] Dihydromorphine (9145) ............... I By Notice dated August 2, 2010, and BILLING CODE 4410–09–P Normorphine (9313) ..................... I published in the Federal Register on Amphetamine (1100) .................... II September 1, 2010, 75 FR 53720, Cody Methamphetamine (1105) ............ II Laboratories, 601 Yellowstone Avenue, DEPARTMENT OF JUSTICE Amobarbital (2125) ....................... II Cody, Wyoming 82414, made Phencyclidine (7471) .................... II Federal Bureau of Investigation Phenylacetone (8501) .................. II application by renewal to the Drug Cocaine (9041) ............................. II Enforcement Administration (DEA) to [Docket No. FBI 150] Codeine (9050) ............................. II be registered as a bulk manufacturer of Dihydrocodeine (9120) ................. II the following basic classes of controlled FBI Records Management Division; Oxycodone (9143) ........................ II substances: National Name Check Program Hydromorphone (9150) ................ II Section; New User Fees Schedule Ecgonine (9180) ........................... II Drug Schedule Hydrocodone (9193) ..................... II AGENCY: Federal Bureau of Investigation Meperidine (9230) ........................ II Dihydromorphine (9145) ............... I (FBI), Justice. Metazocine (9240) ........................ II Amphetamine (1100) .................... II ACTION: Notice. Dextropropoxyphene, bulk (non- II Methamphetamine (1105) ............ II dosage forms) (9273). Amobarbital (2125) ....................... II SUMMARY: Pursuant to 28 CFR Morphine (9300) ........................... II Pentobarbital (2270) ..................... II 20.31(e)(3), this notice establishes a new VerDate Mar<15>2010 16:00 Feb 01, 2011 Jkt 223001 PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 E:\FR\FM\02FEN1.SGM 02FEN1 srobinson on DSKHWCL6B1PROD with NOTICES.